| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 24 |
| 1 | AZATHIOPRINE | 18 |
| 2 | METOPROLOL | 17 |
| 3 | METOPROLOL TARTRATE | 17 |
| 4 | RANITIDINE | 17 |
| 5 | METOPROLOL TARTRATE INJECTION | 16 |
| 6 | SODIUM CHLORIDE | 16 |
| 7 | ESOMEPRAZOLE | 15 |
| 8 | ESOMEPRAZOLE MAGNESIUM | 15 |
| 9 | SODIUM CHLORIDE TABLET | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BULEVIRTIDE | 1 | 0.0104 |
| 1 | ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS | 4 | 0.0037 |
| 2 | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | 1 | 0.0025 |
| 3 | DALBAVANCIN | 2 | 0.0020 |
| 4 | CROMOLYN SODIUM | 7 | 0.0019 |
| 5 | ETOMIDATE | 3 | 0.0013 |
| 6 | EPTIFIBATIDE | 1 | 0.0013 |
| 7 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 8 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 9 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 1 | Proton Pump Inhibitor [EPC] | 26 |
| 2 | Prostacycline Vasodilator [EPC] | 25 |
| 3 | Corticosteroid [EPC] | 24 |
| 4 | Osmotic Laxative [EPC] | 24 |
| 5 | Platinum-based Drug [EPC] | 21 |
| 6 | Purine Antimetabolite [EPC] | 18 |
| 7 | Endothelin Receptor Antagonist [EPC] | 15 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 15 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 3 | Human alpha-1 Proteinase Inhibitor [EPC] | 3 | 0.0007 |
| 4 | Parenteral Iron Replacement [EPC] | 9 | 0.0007 |
| 5 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 6 | Human Immunoglobulin G [EPC] | 12 | 0.0006 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 4 | 0.0004 |
| 9 | Lipid Emulsion [EPC] | 1 | 0.0004 |